melanotic nerve sheath tumor Malignant peripheral A) Malignant melanotic nerve sheath

DPP-4 inhibitors: Linagliptin: hepatobiliary excretion (no dose adjustment required in patients with renal impairment, making it preferred) Other DPP-4 inhibitors (sitagliptin, vildagliptin, saxagliptin, and alogliptin) are predominantly eliminated by the kidneys, so dosage must be adjusted in cases of severe renal dysfunction

A regimen of 500 mg twice daily was given for 12 weeks for dyslipidemia in patients with coronary artery disease without comorbid diabetes, liver disease, or renal disease

Hyperglycemia causes a significant increase in lipid profile levels, which may be related to a lack of insulin

2025;11:31.doi.org/10.1186/s40842-025-00245-5

Trials report administering the peptides late in the evening, usually at bedtime

SAT and OASTL catalyze the last steps of cysteine biosynthesis, whereas GSH1 is the rate-limiting enzyme of GSH biosynthesis, and PCS is involved in phytochelatin biosynthesis (Liszewska et al., 2001